Best Fertility Centre – Dr. Swapna Naik

PGT-A in IVF: embryo chromosome screening guide

Discuss embryo testing as part of your IVF plan

Call +91 76708 04424

PGT-A in IVF: What Embryo Genetic Testing Can and Cannot Tell You

Embryo genetic testing can sound like a way to remove uncertainty from IVF. PGT-A can provide useful chromosome information in selected circumstances, but it cannot guarantee implantation, prevent every miscarriage or promise a healthy baby. Understanding what it measures—and what it does not—is essential before deciding whether to include it in treatment.

Quick Answer

Preimplantation genetic testing for aneuploidy, or PGT-A, analyses cells biopsied from an IVF embryo for chromosome copy-number abnormalities. It is used to inform embryo selection, not to repair embryos or improve egg quality. Its value as routine screening for every IVF patient has not been demonstrated.

What Is PGT-A?

PGT-A screens a small sample of embryo cells for chromosome copy-number abnormalities. Aneuploidy means an abnormal chromosome number; euploidy describes the expected chromosome complement within the scope of the test.

Testing is commonly performed on cells sampled from the trophectoderm of a blastocyst. The trophectoderm contributes mainly to placental tissues. The sample is not every cell in the embryo, and the result is not a complete diagnosis of a future baby’s health.

PGT-A requires embryos created through IVF. If the overall pathway is unfamiliar, the clinic’s IVF treatment overview explains the sequence from stimulation and egg collection to embryo development and transfer.

PGT-A vs PGT-M vs PGT-SR

“Embryo genetic testing” is an umbrella description. Different tests answer different questions. A known inherited condition or parental chromosome rearrangement should prompt appropriate genetic counselling rather than an assumption that PGT-A alone is sufficient.

Different forms of preimplantation genetic testing
Test Main purpose Important limitation
PGT-A Screen embryo biopsy material for aneuploidy. Does not screen for every genetic disease or guarantee a healthy pregnancy.
PGT-M Test for a specified monogenic, or single-gene, condition. Usually requires condition-specific assessment and laboratory preparation.
PGT-SR Assess embryos in the context of certain structural chromosome rearrangements. The test’s ability to distinguish particular outcomes depends on the method and family findings.

The clinic’s preimplantation genetic testing service page introduces PGT. Ask which specific test is proposed, which laboratory will perform it and what it can report.

How Does PGT-A Fit into an IVF Cycle?

  1. Counselling and consent: discuss the question being asked, alternatives, reporting categories, costs and possible outcomes before testing.
  2. IVF treatment: ovarian stimulation, egg collection and fertilisation create embryos for laboratory culture.
  3. Blastocyst assessment and biopsy: suitable embryos are assessed and a small trophectoderm sample is obtained.
  4. Cryopreservation and laboratory analysis: embryos are commonly frozen while biopsy material is tested.
  5. Results review: the team explains the report and how it affects the available options.
  6. Transfer planning: a frozen embryo transfer may be planned if an embryo is considered suitable after counselling.

Not every egg fertilises, not every fertilised egg reaches blastocyst and not every embryo produces an interpretable or transferable result. Discuss this whole pathway, not only the likelihood of success after a selected embryo reaches transfer.

Is Embryo Grading the Same as Chromosome Testing?

No. Morphology grading describes how an embryo looks and develops. PGT-A analyses chromosome-related information in biopsy material. A good-looking embryo is not necessarily euploid, and a euploid result does not guarantee implantation.

Our guide to embryo grading in IVF explains what grades such as 3AA and 4AA describe and why appearance alone is not a prediction of a baby.

Understanding PGT-A Results

Common report categories
Result What it generally means What to discuss
Euploid No reportable chromosome copy-number abnormality detected within the assay’s scope. Does not exclude every genetic condition, birth defect or pregnancy complication.
Aneuploid A chromosome copy-number abnormality is reported. The exact finding, limitations and implications for embryo management.
Mosaic / intermediate result An intermediate copy-number signal may be interpreted as mosaic by the laboratory. Laboratory criteria, uncertainty and specialist genetic counselling.
No result / inconclusive The sample did not produce an interpretable report. Options and trade-offs, including whether re-biopsy would be appropriate.

Why Does a Mosaic Result Need Careful Counselling?

A mosaic report is inferred from the test signal; it is not based on visually counting normal and abnormal cells throughout the embryo. Technical variation and other factors can also contribute to intermediate results. Laboratories may use different reporting thresholds.

The ASRM guidance on mosaic PGT-A results explains why these reports require individualised interpretation. Do not make embryo-disposition decisions from a general online explanation alone.

Does PGT-A Improve IVF Success?

The answer depends on the patient group and the outcome being measured. The ASRM 2024 committee opinion on PGT-A states that its value as routine screening for all IVF patients has not been demonstrated.

Per-transfer success is not the same as cumulative live birth

A per-transfer figure describes outcomes among patients who reached transfer. It may exclude patients who had no blastocyst, no interpretable result or no embryo considered suitable.

A cumulative live-birth discussion considers the overall reproductive outcome across embryos or transfers from a defined treatment episode. Ask exactly which denominator a quoted percentage uses.

Can it prevent miscarriage?

PGT-A may help avoid transfer of embryos with detectable aneuploidy, but it does not prevent every cause of miscarriage. Whether it reduces miscarriage or improves the overall chance of a baby in a particular patient requires a balanced discussion of the evidence and uncertainties.

Who May Consider PGT-A?

Counselling may consider age at egg collection, anticipated blastocyst number, prior IVF history, previous losses, financial implications and personal preferences. These are discussion factors, not automatic indications.

  • Older reproductive age may make embryo aneuploidy more relevant, but age alone does not establish that every patient benefits from testing.
  • With few embryos, the possibility of having none available after testing deserves particular attention.
  • Previous miscarriage does not mean PGT-A addresses every possible cause of pregnancy loss.
  • A known genetic condition or chromosome rearrangement may require a different or additional PGT approach.

Choosing IVF without PGT-A is also an option that can be discussed. Informed consent should include a comparison with not testing, rather than presenting testing as mandatory.

Risks, Costs and Trade-offs

  • Embryo biopsy and laboratory handling are procedures with limitations and potential risks.
  • Embryos are commonly frozen and later warmed; survival cannot be guaranteed for every embryo.
  • False-positive, false-negative, mosaic or inconclusive results may complicate decisions.
  • Re-biopsy can involve additional warming, biopsy and freezing; its risks need separate discussion.
  • Testing may add cost and delay and may leave no embryo considered suitable for transfer.
  • PGT-A cannot increase the number of eggs retrieved, repair chromosome abnormalities or reverse ovarian ageing.

Request a written breakdown covering biopsy, testing, freezing, storage, counselling, possible re-testing and embryo transfer. No clinic-specific prices or success percentages are assumed in this guide.

Is Prenatal Testing Still Relevant?

Yes. PGT-A is not a substitute for prenatal screening and diagnostic-test discussions. After pregnancy, the obstetric and genetics team should review the embryo report and explain the available pregnancy-testing options.

An embryo reported euploid is not a guarantee against every genetic condition or developmental problem. Counselling is especially important following an uncertain or mosaic result.

Questions to Ask Before Consent

  • What specific benefit are we hoping to achieve in my case?
  • How many blastocysts might be available for testing?
  • What is the alternative if we do not use PGT-A?
  • How does the laboratory report mosaic and segmental findings?
  • What happens if there is no result or no suitable embryo?
  • Who provides genetic counselling?
  • What are the complete costs and expected timeline?
  • What prenatal testing will still be discussed?
Request an IVF consultation

Frequently Asked Questions

Is PGT-A the same as PGS?

PGS is an older term used for preimplantation chromosome screening. PGT-A is the current term for testing for aneuploidy, although older and newer laboratory methods are not necessarily equivalent.

Does PGT-A guarantee implantation?

No. A euploid result can inform embryo selection, but implantation and live birth depend on additional embryo, uterine and clinical factors.

Does every IVF patient need PGT-A?

No. Routine screening of all IVF patients has not demonstrated a universal benefit. The decision requires individual counselling.

Does PGT-A test for every genetic disease?

No. It mainly assesses chromosome copy number within the assay’s scope. A known single-gene condition may require PGT-M and condition-specific preparation.

Does a mosaic result describe the entire embryo?

Not definitively. It is an interpretation of the biopsy’s test signal, and technical factors can contribute. Genetic counselling should address the exact report.

What if there are only one or two blastocysts?

Discuss the limited opportunity for embryo selection, the chance of uncertain or abnormal results, procedural trade-offs and the alternative of not testing.

What if no embryo is reported suitable for transfer?

Review the exact findings, laboratory limitations and available options with the treating team and a genetic counsellor where appropriate. Do not assume that every report category has identical implications.

Is pregnancy testing still needed after PGT-A?

Yes. PGT-A does not replace confirmation of pregnancy or prenatal screening and diagnostic-test counselling.

Conclusion

PGT-A is an embryo-selection tool with potential value in selected circumstances and important limitations. A good decision compares testing with not testing, considers the whole IVF pathway and includes a clear plan for uncertain results and pregnancy care.

Dr. Swapna Naik, Founder and Medical Director of Sree Swapna Fertility Centre

About the specialist

Dr. Swapna Naik

Founder & Medical Director
Sree Swapna Fertility Centre

Her clinic profile describes fertility services including IVF, IUI, ovulation induction and fertility preservation. Genetic-test decisions may also require input from the embryology laboratory and a genetic counsellor.

Read Dr. Swapna Naik’s professional profile .

Request an appointment

About This Health Information

Purpose and evidence

This guide provides general education and questions for informed discussion. It does not interpret an individual embryo report or replace reproductive genetic counselling. Supporting professional sources are listed below.

Publisher and commercial context

Sree Swapna Fertility Centre publishes this article and offers fertility services. Appointment and service links lead to the clinic’s own pages. No treatment guarantees pregnancy or live birth.

Questions and corrections

Use the contact page to report a possible error. Include the article title and relevant passage. Do not post genetic reports or other private health information in public comments.

Medical Sources

General educational information only. Do not make testing, embryo-transfer or embryo-disposition decisions from this article alone. Seek individual clinical and genetic counselling.

FERTILITY HELPLINE

Contact the Clinic

Appointment and fertility consultation enquiries.

Not an emergency service. Do not send sensitive medical information through this panel.

Scroll to Top